DK437786D0
(da)
*
|
1986-09-12 |
1986-09-12 |
Nordisk Gentofte |
Insulinprecursorer
|
CA1339416C
(en)
*
|
1987-02-25 |
1997-09-02 |
Liselotte Langkjaer |
Insulin derivatives
|
US4992417A
(en)
*
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogues
|
US4992418A
(en)
*
|
1987-07-17 |
1991-02-12 |
Mount Sinai School Of Medicine |
Superactive human insulin analogue-[10-Aspartic Acid-B]Human Insulin
|
CA1340772C
(en)
*
|
1987-12-30 |
1999-09-28 |
Patricia Tekamp-Olson |
Expression and secretion of heterologous protiens in yeast employing truncated alpha-factor leader sequences
|
ATE93238T1
(de)
*
|
1988-07-20 |
1993-09-15 |
Novo Nordisk As |
Menschliche insulinanalage und zubereitungen daraus.
|
DE3837825A1
(de)
*
|
1988-11-08 |
1990-05-10 |
Hoechst Ag |
Neue insulinderivate, ihre verwendung und eine sie enthaltende pharmazeutische zubereitung
|
JPH04502465A
(ja)
*
|
1988-12-23 |
1992-05-07 |
ノボ ノルディスク アクティーゼルスカブ |
ヒトインシュリン類似物質
|
US5716927A
(en)
*
|
1988-12-23 |
1998-02-10 |
Novo Nordisk A/S |
Insulin analogs having a modified B-chain
|
US5514646A
(en)
*
|
1989-02-09 |
1996-05-07 |
Chance; Ronald E. |
Insulin analogs modified at position 29 of the B chain
|
US5208217A
(en)
*
|
1989-04-20 |
1993-05-04 |
Mount Sinai School Of Medicine Of The City University Of New York |
Hepatospecific insulin analogues
|
ATE120762T1
(de)
*
|
1989-04-20 |
1995-04-15 |
Sinai School Medicine |
Hepatospezifische insulin-analoga.
|
DK155690D0
(da)
*
|
1990-06-28 |
1990-06-28 |
Novo Nordisk As |
Nye peptider
|
DK158390D0
(da)
*
|
1990-07-02 |
1990-07-02 |
Novo Nordisk As |
Nye peptider
|
DK10191D0
(da)
*
|
1991-01-22 |
1991-01-22 |
Novo Nordisk As |
Hidtil ukendte peptider
|
DK33591D0
(sh)
*
|
1991-02-27 |
1991-02-27 |
Novo Nordisk As |
|
TW222643B
(sh)
*
|
1991-06-21 |
1994-04-21 |
Lilly Co Eli |
|
HUT71583A
(en)
*
|
1992-12-18 |
1995-12-28 |
Lilly Co Eli |
Insulin-analogs
|
DK72793D0
(da)
*
|
1993-06-21 |
1993-06-21 |
Novo Nordisk As |
Nyt produkt
|
ATE176482T1
(de)
*
|
1993-06-21 |
1999-02-15 |
Novo Nordisk As |
Asp-b28-insulinkristalle
|
US5474978A
(en)
*
|
1994-06-16 |
1995-12-12 |
Eli Lilly And Company |
Insulin analog formulations
|
US5504188A
(en)
*
|
1994-06-16 |
1996-04-02 |
Eli Lilly And Company |
Preparation of stable zinc insulin analog crystals
|
US5461031A
(en)
*
|
1994-06-16 |
1995-10-24 |
Eli Lilly And Company |
Monomeric insulin analog formulations
|
US5547929A
(en)
*
|
1994-09-12 |
1996-08-20 |
Eli Lilly And Company |
Insulin analog formulations
|
AU3562195A
(en)
*
|
1994-10-04 |
1996-04-26 |
Novo Nordisk A/S |
Preparations containing aspb28 human insulin and nicotinamide
|
US5597893A
(en)
*
|
1994-10-31 |
1997-01-28 |
Eli Lilly And Company |
Preparation of stable insulin analog crystals
|
US5646242A
(en)
|
1994-11-17 |
1997-07-08 |
Eli Lilly And Company |
Selective acylation of epsilon-amino groups
|
US5693609A
(en)
*
|
1994-11-17 |
1997-12-02 |
Eli Lilly And Company |
Acylated insulin analogs
|
YU18596A
(sh)
*
|
1995-03-31 |
1998-07-10 |
Eli Lilly And Company |
Analogne formulacije monomernog insulina
|
US5631347A
(en)
*
|
1995-06-07 |
1997-05-20 |
Eli Lilly And Company |
Reducing gelation of a fatty acid-acylated protein
|
US5700904A
(en)
*
|
1995-06-07 |
1997-12-23 |
Eli Lilly And Company |
Preparation of an acylated protein powder
|
CN1120019C
(zh)
*
|
1996-06-20 |
2003-09-03 |
诺沃挪第克公司 |
含NaCl的胰岛素制品
|
AR012894A1
(es)
|
1997-06-13 |
2000-11-22 |
Lilly Co Eli |
Formulacion de insulina en solucion estable, su uso para preparar un medicamento y proceso para la preparacion de la misma.
|
DE19726167B4
(de)
|
1997-06-20 |
2008-01-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin, Verfahren zu seiner Herstellung und es enthaltende pharmazeutische Zubereitung
|
HUP0004169A3
(en)
|
1997-10-24 |
2001-06-28 |
Lilly Co Eli |
Insoluble insulin compositions and process for production thereof
|
US6531448B1
(en)
|
1997-12-23 |
2003-03-11 |
Eli Lilly And Company |
Insoluble compositions for controlling blood glucose
|
EA003944B1
(ru)
*
|
1998-02-23 |
2003-10-30 |
Ньюрокрайн Байосайенсиз Инк. |
Способы лечения диабета с помощью пептидных аналогов инсулина
|
DE19825447A1
(de)
*
|
1998-06-06 |
1999-12-09 |
Hoechst Marion Roussel De Gmbh |
Neue Insulinanaloga mit erhöhter Zinkbildung
|
US6933272B1
(en)
|
1998-09-22 |
2005-08-23 |
Erik Helmerhorst |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
AUPP609198A0
(en)
*
|
1998-09-22 |
1998-10-15 |
Curtin University Of Technology |
Use of non-peptidyl compounds for the treatment of insulin related ailments
|
DK1141014T3
(da)
|
1999-01-06 |
2005-04-11 |
Genentech Inc |
Insulinlignende vækstfaktor (IGF) i mutantvariant
|
WO2000040612A1
(en)
|
1999-01-06 |
2000-07-13 |
Genentech, Inc. |
Insulin-like growth factor (igf) i mutant variants
|
US6746853B1
(en)
*
|
1999-05-19 |
2004-06-08 |
Xencor, Inc. |
Proteins with insulin-like activity useful in the treatment of diabetes
|
CN1125081C
(zh)
*
|
1999-09-08 |
2003-10-22 |
中国科学院上海生物化学研究所 |
重组天然和新型人胰岛素及其制备方法
|
US7022674B2
(en)
*
|
1999-12-16 |
2006-04-04 |
Eli Lilly And Company |
Polypeptide compositions with improved stability
|
EP1265630B1
(en)
|
2000-03-24 |
2006-06-07 |
Genentech, Inc. |
Use of insulin for the treatment of cartilagenous disorders
|
JP2003532691A
(ja)
*
|
2000-05-05 |
2003-11-05 |
ノボ ノルディスク アクティーゼルスカブ |
重症疾患神経障害
|
AU2001263215A1
(en)
|
2000-05-16 |
2001-11-26 |
Genentech Inc. |
Method for treating cartilage disorders
|
AR025646A1
(es)
*
|
2000-09-13 |
2002-12-04 |
Beta Lab Sa |
Cepa de levaduras metilotroficas recombinantes productoras de un precursor de insulina, construcciones de adn y metodo para obtener la cepa.
|
US7638618B2
(en)
|
2001-02-20 |
2009-12-29 |
Sanofi-Aventis Deutschland Gmbh |
Nucleic acids encoding a hirudin and pro-insulin as superscretable peptides and for parallel improvement of the exported forms of one or more polypeptides of interest
|
US7202059B2
(en)
|
2001-02-20 |
2007-04-10 |
Sanofi-Aventis Deutschland Gmbh |
Fusion proteins capable of being secreted into a fermentation medium
|
DE10114178A1
(de)
|
2001-03-23 |
2002-10-10 |
Aventis Pharma Gmbh |
Zinkfreie und zinkarme Insulinzubereitungen mit verbesserter Stabilität
|
EP1444219A1
(en)
|
2001-10-12 |
2004-08-11 |
Novo Nordisk A/S |
Substituted piperidines and their use for the treatment of diseases related to the histamine h3 receptor
|
KR100925381B1
(ko)
|
2001-11-19 |
2009-11-09 |
노보 노르디스크 에이/에스 |
인슐린 화합물의 제조 방법
|
GB0206792D0
(en)
|
2002-03-22 |
2002-05-01 |
Leuven K U Res & Dev |
Normoglycemia
|
DE10227232A1
(de)
|
2002-06-18 |
2004-01-15 |
Aventis Pharma Deutschland Gmbh |
Saure Insulinzubereitungen mit verbesserter Stabilität
|
US7193035B2
(en)
|
2002-10-29 |
2007-03-20 |
Sanofi-Aventis Deutschland Gmbh |
Crystals of insulin analogs and processes for their preparation
|
WO2004089470A2
(en)
|
2003-04-11 |
2004-10-21 |
Novo Nordisk A/S |
New amide derivatives and pharmaceutical use thereof
|
US7871607B2
(en)
*
|
2003-03-05 |
2011-01-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminoglycanases
|
JP4781264B2
(ja)
|
2003-06-27 |
2011-09-28 |
ノボ・ノルデイスク・エー/エス |
医療用液体組成物の高水分遮断容器
|
US20060183667A1
(en)
*
|
2003-07-11 |
2006-08-17 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
EP1644411A2
(en)
*
|
2003-07-11 |
2006-04-12 |
Novo Nordisk A/S |
Stabilised insulin compositions
|
ES2328579T3
(es)
*
|
2003-07-25 |
2009-11-16 |
Conjuchem Biotechnologies Inc. |
Derivados de insulina de larga duracion y procedimientos asociados.
|
EP1660531A2
(en)
|
2003-08-05 |
2006-05-31 |
Novo Nordisk A/S |
Novel insulin derivatives
|
PT2275439E
(pt)
|
2003-08-05 |
2014-06-25 |
Novo Nordisk As |
Novos derivados de insulina
|
JP4800959B2
(ja)
*
|
2003-11-13 |
2011-10-26 |
ノヴォ ノルディスク アー/エス |
糖尿病及び過食症を治療するためのglp−1ペプチド及び短時間作用型インスリンペプチドを含む、非経口投与用の可溶性医薬組成物
|
US20060287221A1
(en)
|
2003-11-13 |
2006-12-21 |
Novo Nordisk A/S |
Soluble pharmaceutical compositions for parenteral administration comprising a GLP-1 peptide and an insulin peptide of short time action for treatment of diabetes and bulimia
|
PT3300721T
(pt)
|
2003-11-20 |
2019-06-06 |
Novo Nordisk As |
Formulações peptidicas contendo propileno glicol que sao ideais para a produção e para utilizacao em dispositivos de injeção
|
JP5697831B2
(ja)
|
2003-12-03 |
2015-04-08 |
ノヴォ ノルディスク アー/エス |
単鎖インシュリン
|
ATE483580T1
(de)
|
2003-12-22 |
2010-10-15 |
Novo Nordisk As |
Durchsichtiger, flexibler, undurchlässiger kunststoffbehälter zur lagerung von pharmazeutischen flüssigkeiten
|
ATE550041T1
(de)
|
2004-01-21 |
2012-04-15 |
Novo Nordisk Healthcare Ag |
Transglutaminase-vermittelte konjugation von peptiden
|
EP2626368B1
(en)
|
2004-07-19 |
2016-12-21 |
Biocon Limited |
Insulin-oligomer conjugates, formulations and uses thereof
|
CA2582363C
(en)
|
2004-11-04 |
2013-09-10 |
Hunter Douglas Inc. |
Single-track stacking panel covering for an architectural opening
|
US7833513B2
(en)
|
2004-12-03 |
2010-11-16 |
Rhode Island Hospital |
Treatment of Alzheimer's Disease
|
ES2490243T3
(es)
|
2005-02-02 |
2014-09-03 |
Novo Nordisk A/S |
Derivados de insulina
|
JP4933455B2
(ja)
|
2005-02-02 |
2012-05-16 |
ノヴォ ノルディスク アー/エス |
新規のインスリン誘導体
|
US8501739B2
(en)
|
2005-07-04 |
2013-08-06 |
High Point Pharmaceuticals, Llc |
Medicaments
|
EP1910317B1
(en)
|
2005-07-20 |
2013-07-03 |
Eli Lilly And Company |
1-amino linked compounds
|
EP1917363B1
(en)
|
2005-08-16 |
2011-06-22 |
Novo Nordisk A/S |
Method for making mature insulin polypeptides
|
ATE517919T1
(de)
|
2005-09-14 |
2011-08-15 |
Sanofi Aventis Deutschland |
Spaltung von insulinvorstufen durch eine trypsinvariante
|
PT1951658E
(pt)
|
2005-11-17 |
2012-11-12 |
Lilly Co Eli |
Antagonistas do receptor do glucagon, preparação e utilizações terapêuticas
|
DK1969004T3
(da)
|
2005-12-28 |
2011-11-28 |
Novo Nordisk As |
Insulinsammensætninger og metode til at lave en sammensætning
|
US8343914B2
(en)
*
|
2006-01-06 |
2013-01-01 |
Case Western Reserve University |
Fibrillation resistant proteins
|
US20090069216A1
(en)
*
|
2006-02-21 |
2009-03-12 |
Novo Nordisk A/S |
Single-Chain Insulin Analogues and Pharmaceutical Formulations Thereof
|
ES2387955T3
(es)
|
2006-02-27 |
2012-10-04 |
Novo Nordisk A/S |
Derivados de insulina
|
EP1996224B1
(en)
|
2006-03-15 |
2012-11-07 |
Novo Nordisk A/S |
Mixtures of amylin and insulin
|
AU2007229492B2
(en)
|
2006-03-28 |
2011-11-03 |
High Point Pharmaceuticals, Llc |
Benzothiazoles having histamine H3 receptor activity
|
DK2049475T3
(da)
|
2006-04-24 |
2012-03-05 |
Lilly Co Eli |
Cyclohexyl-substituerede pyrrolidinoner som inhibitorer af 11-beta-hydroxysteroid dehydrogenase1
|
JP5269766B2
(ja)
|
2006-05-09 |
2013-08-21 |
ノボ・ノルデイスク・エー/エス |
インスリン誘導体
|
CA2649235A1
(en)
|
2006-05-09 |
2007-11-15 |
Frantisek Hubalek |
Insulin derivative
|
KR20090040259A
(ko)
|
2006-05-29 |
2009-04-23 |
하이 포인트 파마슈티칼스, 엘엘씨 |
3-(1,3-벤조디옥솔-5-일)-6-(4-시클로프로필피페라진-1-일)-피리다진, 그것의 염과 용매화합물 및 그것의 히스타민 h3 수용체 안타고니스트로서의 용도
|
JP2009539778A
(ja)
*
|
2006-06-08 |
2009-11-19 |
ダイアベコア メディカル インコーポレイテッド |
インスリンオリゴマー誘導体
|
DE102006031962A1
(de)
|
2006-07-11 |
2008-01-17 |
Sanofi-Aventis Deutschland Gmbh |
Amidiertes Insulin Glargin
|
DE102006031955A1
(de)
|
2006-07-11 |
2008-01-17 |
Sanofi-Aventis Deutschland Gmbh |
Verfahren zur Herstellung von Insulinanaloga mit dibasischem B-Kettenende
|
EP2049149B1
(en)
|
2006-07-31 |
2015-04-15 |
Novo Nordisk A/S |
Pegylated extended insulins
|
PT2074141T
(pt)
|
2006-09-22 |
2016-11-10 |
Novo Nordisk As |
Análogos de insulina resistentes a proteases
|
EP2074140B8
(en)
|
2006-10-04 |
2015-10-28 |
Case Western Reserve University |
Fibrillation-resistant insulin and insulin analogues
|
WO2008049711A1
(en)
*
|
2006-10-27 |
2008-05-02 |
Novo Nordisk A/S |
Peptide extended insulins
|
US20120214963A1
(en)
*
|
2011-02-23 |
2012-08-23 |
Elona Biotechnologies |
Aspart proinsulin compositions and methods of producing aspart insulin analogs therefrom
|
US10100098B2
(en)
|
2006-12-13 |
2018-10-16 |
Stelis Biopharma Private Limited |
Insulin production methods and proinsulin constructs
|
US9387176B2
(en)
|
2007-04-30 |
2016-07-12 |
Novo Nordisk A/S |
Method for drying a protein composition, a dried protein composition and a pharmaceutical composition comprising the dried protein
|
WO2008139496A1
(en)
*
|
2007-05-16 |
2008-11-20 |
Bigtec Private Limited |
Recombinant human insulin and a method thereof
|
KR20100017667A
(ko)
|
2007-06-01 |
2010-02-16 |
노보 노르디스크 에이/에스 |
안정한 비-수성의 약학 조성물
|
EP2164466A1
(en)
|
2007-06-01 |
2010-03-24 |
Novo Nordisk A/S |
Spontaneously dispersible preconcentrates including a peptide drug in a solid or semisolid carrier
|
US9034818B2
(en)
|
2007-06-13 |
2015-05-19 |
Novo Nordisk A/S |
Pharmaceutical formulations comprising an insulin derivative
|
US8575096B2
(en)
|
2007-08-13 |
2013-11-05 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
EP2178911A2
(en)
*
|
2007-08-13 |
2010-04-28 |
Novo Nordisk A/S |
Rapid acting insulin analogues
|
KR20100053561A
(ko)
|
2007-08-15 |
2010-05-20 |
노보 노르디스크 에이/에스 |
아실 및 알킬렌 글리콜 부분을 갖는 인슐린 유사체
|
US8962794B2
(en)
|
2007-08-15 |
2015-02-24 |
Novo Nordisk A/S |
Insulins with an acyl moiety comprising repeating units of alkylene glycol containing amino acids
|
ES2632504T3
(es)
|
2007-11-20 |
2017-09-13 |
Ambrx, Inc. |
Polipéptidos de insulina modificados y sus usos
|
CA2711749A1
(en)
|
2008-01-09 |
2009-07-16 |
Sanofi-Aventis Deutschland Gmbh |
Novel insulin derivatives having an extremely delayed time-action profile
|
PL2254906T3
(pl)
|
2008-03-18 |
2017-04-28 |
Novo Nordisk A/S |
Stabilizowane względem proteaz, acylowane analogi insuliny
|
EP2262539B1
(en)
|
2008-04-01 |
2015-07-15 |
Novo Nordisk A/S |
Insulin albumin conjugates
|
US8993516B2
(en)
*
|
2008-04-14 |
2015-03-31 |
Case Western Reserve University |
Meal-time insulin analogues of enhanced stability
|
NZ588857A
(en)
*
|
2008-04-22 |
2012-07-27 |
Univ Case Western Reserve |
Isoform-specific insulin analogue for control blood sugar levels
|
TWI394580B
(zh)
|
2008-04-28 |
2013-05-01 |
Halozyme Inc |
超快起作用胰島素組成物
|
TWI451876B
(zh)
|
2008-06-13 |
2014-09-11 |
Lilly Co Eli |
聚乙二醇化之離脯胰島素化合物
|
US9200053B2
(en)
|
2008-07-31 |
2015-12-01 |
Case Western Reserve University |
Insulin analogues containing penta-fluoro-Phenylalanine at position B24
|
KR20120129875A
(ko)
|
2008-07-31 |
2012-11-28 |
케이스 웨스턴 리저브 유니버시티 |
염소화 아미노산을 갖는 인슐린 유사체
|
BRPI0823004B8
(pt)
|
2008-08-07 |
2021-05-25 |
Biocon Ltd |
processo para preparação de compostos de insulina
|
LT2349324T
(lt)
|
2008-10-17 |
2017-12-27 |
Sanofi-Aventis Deutschland Gmbh |
Insulino ir glp-1 agonisto derinys
|
DE102008053048A1
(de)
|
2008-10-24 |
2010-04-29 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102008051834A1
(de)
|
2008-10-17 |
2010-04-22 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
DE102009038210A1
(de)
|
2009-08-20 |
2011-03-03 |
Sanofi-Aventis Deutschland Gmbh |
Kombination von einem Insulin und einem GLP-1-Agonisten
|
CA2738615A1
(en)
|
2008-10-30 |
2010-05-06 |
Novo Nordisk A/S |
Treating diabetes melitus using insulin injections with less than daily injection frequency
|
US8927549B2
(en)
|
2008-11-21 |
2015-01-06 |
High Point Pharmaceuticals, Llc |
Adamantyl benzamide derivatives
|
FR2943538B1
(fr)
|
2009-03-27 |
2011-05-20 |
Adocia |
Formulation a action rapide d'insuline recombinante humaine
|
US9018190B2
(en)
|
2009-03-27 |
2015-04-28 |
Adocia |
Functionalized oligosaccharides
|
MA33442B1
(fr)
|
2009-07-06 |
2012-07-03 |
Sanofi Aventis Deutschland |
Préparations d'insuline contenant de la méthionine
|
WO2011003823A1
(de)
|
2009-07-06 |
2011-01-13 |
Sanofi-Aventis Deutschland Gmbh |
Langsamwirkende insulinzubereitungen
|
TW201105346A
(en)
|
2009-07-06 |
2011-02-16 |
Sanofi Aventis Deutschland |
Heat-stable and vibration-stable insulin preparations
|
ES2636741T3
(es)
|
2009-07-31 |
2017-10-09 |
Sanofi-Aventis Deutschland Gmbh |
Composición de insulina de acción prolongada
|
MA33467B1
(fr)
|
2009-07-31 |
2012-07-03 |
Sanofi Aventis Deutschland |
Promédicaments comprenant un conjugué insuline-lieur
|
US8399407B2
(en)
*
|
2009-09-17 |
2013-03-19 |
Case Western Reserve University |
Non-standard insulin analogues
|
PL2498801T3
(pl)
|
2009-11-13 |
2018-08-31 |
Sanofi Aventis Deutschland |
Kompozycja farmaceutyczna zawierająca desPro<sup>36</sup>eksendyno-4(1-39)-Lys6-NH2 i metioninę
|
ES2534191T3
(es)
|
2009-11-13 |
2015-04-20 |
Sanofi-Aventis Deutschland Gmbh |
Composición farmacéutica que comprende un agonista de GLP-1, una insulina y metionina
|
US8637096B2
(en)
|
2009-12-04 |
2014-01-28 |
Curtis C. Stojan |
Compositions and method for enhancing insulin activity
|
BR112012014025A2
(pt)
|
2009-12-11 |
2017-01-31 |
Univ Case Western Reserve |
análogo de insulina, ácido nucleico, vetor de expressão, célula hospedeira e método de tratar um paciente
|
EP2359843A1
(en)
|
2010-01-21 |
2011-08-24 |
Sanofi |
Pharmaceutical composition for treating a metabolic syndrome
|
UY33326A
(es)
|
2010-04-14 |
2011-12-01 |
Sanofi Aventis |
Conjugados de insulina-sirna
|
AU2011252127B2
(en)
|
2010-05-10 |
2014-02-20 |
Novo Nordisk A/S |
Process for the preparation of insulin-zinc complexes
|
US8940860B2
(en)
|
2010-06-16 |
2015-01-27 |
Indiana University Research And Technology Corporation |
Single-chain insulin agonists exhibiting high activity at the insulin receptor
|
WO2011161125A1
(en)
*
|
2010-06-23 |
2011-12-29 |
Novo Nordisk A/S |
Insulin derivatives containing additional disulfide bonds
|
CA2808596C
(en)
|
2010-08-17 |
2020-12-15 |
Ambrx, Inc. |
Modified relaxin polypeptides and their uses
|
HUE031181T2
(en)
|
2010-08-30 |
2017-06-28 |
Sanofi Aventis Deutschland |
Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
|
EP2438930A1
(en)
|
2010-09-17 |
2012-04-11 |
Sanofi-Aventis Deutschland GmbH |
Prodrugs comprising an exendin linker conjugate
|
US20130261051A1
(en)
|
2010-10-27 |
2013-10-03 |
Thue Johansen |
Treating Diabetes Melitus Using Insulin Injections Administered With Varying Injection Intervals
|
BR112013010345A2
(pt)
|
2010-10-27 |
2017-07-25 |
Novo Nordisk As |
tratamento de diabetes melitus usando as injeções de insulina administradas com intervalos de variação da injeção
|
WO2012080320A1
(en)
|
2010-12-14 |
2012-06-21 |
Novo Nordisk A/S |
Fast-acting insulin in combination with long-acting insulin
|
KR20140007377A
(ko)
*
|
2011-02-01 |
2014-01-17 |
노보 노르디스크 에이/에스 |
인슐린의 정제
|
WO2012104834A1
(en)
|
2011-02-03 |
2012-08-09 |
Pharmedica Ltd. |
New oral dissolving films for insulin administration, for treating diabetes
|
WO2012115637A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Aspart proinsulin compositions and methods of producing aspart insulin analogs
|
WO2012115638A1
(en)
|
2011-02-23 |
2012-08-30 |
Elona Biotechnologies |
Glargine proinsulin compositions and methods of producing glargine insulin analogs therefrom
|
WO2012123519A2
(en)
|
2011-03-15 |
2012-09-20 |
Novo Nordisk A/S |
Human insulin analogues and derivatives comprising cysteine substitutions
|
US9821032B2
(en)
|
2011-05-13 |
2017-11-21 |
Sanofi-Aventis Deutschland Gmbh |
Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
|
US20130011378A1
(en)
|
2011-06-17 |
2013-01-10 |
Tzung-Horng Yang |
Stable formulations of a hyaluronan-degrading enzyme
|
EP2548570A1
(en)
|
2011-07-19 |
2013-01-23 |
Sanofi |
Pharmaceutical composition for treating a metabolic syndrome
|
CN108079281A
(zh)
|
2011-08-29 |
2018-05-29 |
赛诺菲-安万特德国有限公司 |
用于2型糖尿病患者中的血糖控制的药物组合
|
AR087744A1
(es)
|
2011-09-01 |
2014-04-16 |
Sanofi Aventis Deutschland |
Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
|
US20130231281A1
(en)
|
2011-11-02 |
2013-09-05 |
Adocia |
Rapid acting insulin formulation comprising an oligosaccharide
|
WO2013086927A1
(zh)
*
|
2011-12-15 |
2013-06-20 |
上海恒瑞医药有限公司 |
人胰岛素类似物及其酰化衍生物
|
US9573987B2
(en)
|
2011-12-20 |
2017-02-21 |
Indiana University Research And Technology Corporation |
CTP-based insulin analogs for treatment of diabetes
|
MX2014012096A
(es)
|
2012-04-11 |
2014-11-21 |
Novo Nordisk As |
Formulaciones de insulina.
|
BR112014026442A8
(pt)
|
2012-05-01 |
2018-01-16 |
Novo Nordisk As |
combinação para alcançar o controle glicêmico, seu uso, e composição farmacêutica.
|
WO2013173923A1
(en)
|
2012-05-25 |
2013-11-28 |
Diamedica, Inc. |
Formulations of human tissue kallikrein-1 for parenteral delivery and related methods
|
SI2854841T1
(sl)
|
2012-06-04 |
2017-06-30 |
Diamedica Inc. |
Glikozilacijske izooblike humanega tkivnega kalikreina-1
|
AU2013323669B2
(en)
|
2012-09-26 |
2018-03-01 |
Indiana University Research And Technology Corporation |
Insulin analog dimers
|
ES2670969T3
(es)
|
2012-11-13 |
2018-06-04 |
Adocia |
Formulación de acción rápida de insulina que comprende un compuesto aniónico sustituido
|
US9707276B2
(en)
|
2012-12-03 |
2017-07-18 |
Merck Sharp & Dohme Corp. |
O-glycosylated carboxy terminal portion (CTP) peptide-based insulin and insulin analogues
|
US9867869B2
(en)
|
2012-12-12 |
2018-01-16 |
Massachusetts Institute Of Technology |
Insulin derivatives for diabetes treatment
|
MX360420B
(es)
|
2012-12-19 |
2018-10-31 |
Wockhardt Ltd |
Una composicion acuosa estable que comprende insulina humana o un analogo o derivado de la misma.
|
JP2016505601A
(ja)
|
2012-12-26 |
2016-02-25 |
ウォックハート リミテッド |
医薬組成物
|
TWI780236B
(zh)
|
2013-02-04 |
2022-10-11 |
法商賽諾菲公司 |
胰島素類似物及/或胰島素衍生物之穩定化醫藥調配物
|
AU2014241743B2
(en)
|
2013-03-14 |
2018-07-05 |
Indiana University Research And Technology Corporation |
Insulin-incretin conjugates
|
US10137172B2
(en)
|
2013-04-30 |
2018-11-27 |
Novo Nordisk A/S |
Administration regime
|
RU2016107610A
(ru)
|
2013-09-30 |
2017-11-03 |
Вокхардт Лимитед |
Фармацевтическая композиция
|
CA2926701A1
(en)
|
2013-10-07 |
2015-04-16 |
Novo Nordisk A/S |
Novel derivative of an insulin analogue
|
KR20160104724A
(ko)
|
2014-01-09 |
2016-09-05 |
사노피 |
인슐린 유사체 및/또는 인슐린 유도체의 안정화된 약제학적 제형
|
SG11201604708VA
(en)
|
2014-01-09 |
2016-07-28 |
Sanofi Sa |
Stabilized glycerol free pharmaceutical formulations of insulin analogues and/or insulin derivatives
|
CN114939156A
(zh)
|
2014-01-09 |
2022-08-26 |
赛诺菲 |
门冬胰岛素的稳定化药物制剂
|
US9795678B2
(en)
|
2014-05-14 |
2017-10-24 |
Adocia |
Fast-acting insulin composition comprising a substituted anionic compound and a polyanionic compound
|
FR3020947B1
(fr)
|
2014-05-14 |
2018-08-31 |
Adocia |
Composition aqueuse comprenant au moins une proteine et un agent solubilisant, sa preparation et ses utilisations
|
US9656017B2
(en)
|
2014-06-20 |
2017-05-23 |
Howard E. Greene |
Infusion delivery devices and methods
|
WO2016001862A1
(en)
|
2014-07-04 |
2016-01-07 |
Wockhardt Limited |
Extended release formulations of insulins
|
US10232020B2
(en)
|
2014-09-24 |
2019-03-19 |
Indiana University Research And Technology Corporation |
Incretin-insulin conjugates
|
JP6829928B2
(ja)
|
2014-10-06 |
2021-02-17 |
ケース ウェスタン リザーブ ユニバーシティCase Western Reserve University |
二相性単鎖インスリン類似体
|
PH12017500935A1
(en)
|
2014-11-21 |
2017-11-27 |
Merck Sharp & Dohme |
Insulin receptor partial agonists
|
US9950039B2
(en)
|
2014-12-12 |
2018-04-24 |
Sanofi-Aventis Deutschland Gmbh |
Insulin glargine/lixisenatide fixed ratio formulation
|
AR102869A1
(es)
|
2014-12-16 |
2017-03-29 |
Lilly Co Eli |
Composiciones de insulina de rápida acción
|
CN105884879A
(zh)
*
|
2015-01-26 |
2016-08-24 |
漳州博欣生物技术有限公司 |
一种胰岛素类似物的化学合成方法
|
TWI748945B
(zh)
|
2015-03-13 |
2021-12-11 |
德商賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患治療
|
TW201705975A
(zh)
|
2015-03-18 |
2017-02-16 |
賽諾菲阿凡提斯德意志有限公司 |
第2型糖尿病病患之治療
|
AU2016311283B2
(en)
|
2015-08-25 |
2020-10-08 |
Novo Nordisk A/S |
Novel insulin derivatives and the medical uses hereof
|
JO3749B1
(ar)
|
2015-08-27 |
2021-01-31 |
Lilly Co Eli |
تركيبات إنسولين سريعة المفعول
|
FR3043557B1
(fr)
|
2015-11-16 |
2019-05-31 |
Adocia |
Composition a action rapide d'insuline comprenant un citrate substitue
|
US20190142963A1
(en)
|
2016-04-15 |
2019-05-16 |
Richard D. DiMarchi |
Fgf21 c-terminal peptide optimization
|
GB201607918D0
(en)
|
2016-05-06 |
2016-06-22 |
Arecor Ltd |
Novel formulations
|
EP3463429A4
(en)
|
2016-05-24 |
2020-07-22 |
Merck Sharp & Dohme Corp. |
PARTIAL INSULIN RECEPTOR AGONISTS AND GLP-1 ANALOGUES
|
EP3463413A4
(en)
|
2016-05-25 |
2020-03-04 |
Merck Sharp & Dohme Corp. |
PARTIAL INSULIN RECEPTOR AGONISTS
|
CN108463468B
(zh)
|
2016-08-02 |
2022-03-04 |
江苏恒瑞医药股份有限公司 |
一种人胰岛素或其类似物的酰化衍生物
|
EP3518893A1
(en)
|
2016-09-29 |
2019-08-07 |
Arecor Limited |
Novel formulations
|
EP3554534B1
(en)
|
2016-12-16 |
2021-06-23 |
Novo Nordisk A/S |
Insulin containing pharmaceutical compositions
|
CA3054962A1
(en)
|
2017-03-09 |
2018-09-13 |
Rick PAULS |
Dosage forms of tissue kallikrein 1
|
GB201707188D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707187D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
GB201707189D0
(en)
|
2017-05-05 |
2017-06-21 |
Arecor Ltd |
Novel formulations
|
KR20190140048A
(ko)
|
2017-06-01 |
2019-12-18 |
일라이 릴리 앤드 캄파니 |
신속-작용 인슐린 조성물
|
EP3668892A1
(en)
|
2017-08-17 |
2020-06-24 |
Novo Nordisk A/S |
Novel acylated insulin analogues and uses thereof
|
CN112040928A
(zh)
|
2018-04-04 |
2020-12-04 |
艾瑞克有限公司 |
用于递送胰岛素化合物的医用输注泵系统
|
IL277721B2
(en)
|
2018-04-04 |
2024-03-01 |
Arecor Ltd |
Medical infusion pump for administering an insulin compound
|
CN112004521A
(zh)
|
2018-04-04 |
2020-11-27 |
艾瑞克有限公司 |
用于递送胰岛素化合物的医用输注泵系统
|
US10335464B1
(en)
|
2018-06-26 |
2019-07-02 |
Novo Nordisk A/S |
Device for titrating basal insulin
|
EP3845240A4
(en)
*
|
2018-09-12 |
2021-11-03 |
Amphastar Nanjing Pharmaceuticals, Inc. |
NEW STRUCTURE OF PROINSULIN ASPARTE AND METHOD FOR PREPARING INSULIN ASPARTE
|
KR20200082618A
(ko)
|
2018-12-31 |
2020-07-08 |
주식회사 폴루스 |
인슐린 과발현용 램프 태그 및 이를 이용한 인슐린의 제조방법
|
EP4073097A1
(en)
*
|
2019-12-11 |
2022-10-19 |
Novo Nordisk A/S |
Novel insulin analogues and uses thereof
|
BR112022013042A2
(pt)
|
2019-12-30 |
2022-10-18 |
Gan & Lee Pharmaceuticals Co Ltd |
Composto da fórmula b, formulação farmacêutica, composição farmacêutica, método para tratar ou prevenir hiperglicemia, diabetes e/ou obesidade
|
KR20220121833A
(ko)
|
2019-12-30 |
2022-09-01 |
간 앤 리 파마슈티칼스 컴퍼니, 리미티드 |
인슐린 유도체
|
GB202004814D0
(en)
|
2020-04-01 |
2020-05-13 |
Arecor Ltd |
Novel formulations
|
WO2023225534A1
(en)
|
2022-05-18 |
2023-11-23 |
Protomer Technologies Inc. |
Aromatic boron-containing compounds and related insulin analogs
|